| scholarly article | Q13442814 |
| P50 | author | Leif Friberg | Q45343642 |
| P2093 | author name string | L Bergfeldt | |
| P2860 | cites work | Validation of Clinical Classification Schemes for Predicting Stroke | Q29028208 |
| Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study | Q29614197 | ||
| External review and validation of the Swedish national inpatient register | Q33928068 | ||
| Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study | Q34054106 | ||
| A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey | Q34105149 | ||
| Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators | Q34506737 | ||
| Quality of life in patients with atrial fibrillation: a systematic review | Q34519858 | ||
| Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation | Q34561536 | ||
| Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation | Q35003773 | ||
| Atrial fibrillation: the cost of illness in Sweden | Q35178044 | ||
| Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study | Q36001150 | ||
| The net clinical benefit of warfarin anticoagulation in atrial fibrillation | Q37421352 | ||
| Impact of atrial fibrillation on the risk of death: the Framingham Heart Study | Q45222306 | ||
| Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study | Q45343563 | ||
| Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation | Q46142380 | ||
| Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy | Q46883849 | ||
| Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). | Q51104394 | ||
| Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. | Q53062472 | ||
| A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. | Q55036185 | ||
| 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Q56986288 | ||
| Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study | Q57260383 | ||
| 2012 focused update of the ESC Guidelines for the management of atrial fibrillation | Q57312493 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P304 | page(s) | 461-468 | |
| P577 | publication date | 2013-08-07 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Atrial fibrillation prevalence revisited | |
| P478 | volume | 274 |
| Q39787308 | A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras |
| Q51740771 | A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study). |
| Q49258898 | A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care. |
| Q90372315 | A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK Project |
| Q39773766 | A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme |
| Q42650117 | Age-dependent atrial arrhythmic phenotype secondary to mitochondrial dysfunction in Pgc-1β deficient murine hearts |
| Q38830818 | Analysis of Circulating miR-1, miR-23a, and miR-26a in Atrial Fibrillation Patients Undergoing Coronary Bypass Artery Grafting Surgery |
| Q28652182 | Assessment of atrial fibrillation and vulnerability in patients with Wolff-Parkinson-White syndrome using two-dimensional speckle tracking echocardiography |
| Q88995509 | Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation: a cohort study in primary care |
| Q58130007 | Atrial Fibrillation Detection Using a Novel Cardiac Ambulatory Monitor Based on Photo-Plethysmography at the Wrist |
| Q90858052 | Atrial Fibrillation Detection from Wrist Photoplethysmography Signals Using Smartwatches |
| Q90283791 | Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study |
| Q36274149 | Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea. |
| Q98770613 | Atrial fibrillation and cancer; understanding the mysterious relationship through a systematic review |
| Q36368656 | Atrial fibrillation and physical activity: Should we exercise caution? |
| Q40124722 | Atrial fibrillation in immigrant groups: a cohort study of all adults 45 years of age and older in Sweden |
| Q58543221 | Atrial fibrillation in immigrants under the age of 45 y in Sweden |
| Q39154824 | Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). |
| Q35205077 | Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss? |
| Q43171698 | Calcium in atrial fibrillation - pulling the trigger or not? |
| Q38281320 | Catheter ablation versus anti-arrhythmic drug therapy for the management of a trial fibrillation: a meta-analysis |
| Q34781621 | Characterization of patients with atrial fibrillation not treated with oral anticoagulants |
| Q47681782 | Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment |
| Q40267269 | Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation |
| Q47148155 | Cost of illness of atrial fibrillation: a nationwide study of societal impact |
| Q38878668 | Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis |
| Q54559714 | Echocardiographic measures of atrial function may predict atrial fibrillation in stroke patients. |
| Q35600341 | Elevated blood lipids are uncommon in patients with post-polio syndrome--a cross sectional study |
| Q37456935 | Emergency Department Readmission in Elderly Patients After Acute Rhythm or Rate Control Treatment for Atrial Fibrillation |
| Q28315439 | Epidemiology of atrial fibrillation: European perspective |
| Q37157549 | European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation |
| Q36621337 | Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study |
| Q40140300 | Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs. |
| Q46164015 | Fibrillation auriculaire et activité physique: Faut-il être prudent? |
| Q61814407 | Gender differences and management of stroke risk of nonvalvular atrial fibrillation in an upper middle-income country: Insights from the CARMEN-AF registry |
| Q35223184 | Global epidemiology of atrial fibrillation |
| Q61806675 | Handheld ECG Tracking of in-hOspital Atrial Fibrillation The HECTO-AF trial Clinical Study Protocol |
| Q93179574 | Heart failure in immigrant groups: a cohort study of adults aged 45 years and over in Sweden |
| Q55339489 | IL‐10(‐592A/C) gene variant a predictor of postoperative atrial fibrillation in the north Indian population. |
| Q38821143 | Impact of atrial fibrillation detected by extended monitoring-A population-based cohort study. |
| Q37616166 | Incidence, type of atrial fibrillation and risk factors for stroke: a population-based cohort study |
| Q92515835 | Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation-Compliance and ease of use in an ambulatory elderly population |
| Q91130357 | Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management |
| Q89365749 | Is atrial fibrillation a risk factor for in-hospital cardiac arrest?: a Swedish retrospective cohort study |
| Q36189151 | Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla® Flex II Occluder |
| Q92702422 | Mobile Self-Monitoring ECG Devices to Diagnose Arrhythmia that Coincide with Palpitations: A Scoping Review |
| Q37556419 | Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study. |
| Q37468892 | Optimization Of Stroke Prophylaxis Strategies In Nonvalvular AF -Drugs, Devices Or Both? |
| Q36802853 | Optimization of Stroke Prophylaxis Strategies in Nonvalvular AF - Drugs, Devices or Both? |
| Q26827576 | Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it? |
| Q33637662 | Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients |
| Q54975902 | Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy. |
| Q92310541 | Patients' Experiences of Living with Atrial Fibrillation: A Mixed Methods Study |
| Q64939076 | Post-cardioversion Improvement in LV Function Defined by 4D Flow Patterns and Energetics in Patients With Atrial Fibrillation. |
| Q91645788 | Prevalence and Incidence of Atrial Fibrillation and Other Arrhythmias in the General Older Population: Findings From the Swedish National Study on Aging and Care |
| Q41075201 | Prevalence and antithrombotic management of atrial fibrillation in hospitalised patients |
| Q64990311 | Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study. |
| Q47136909 | Pro-arrhythmic atrial phenotypes in incrementally paced murine Pgc1β-/- hearts: effects of age. |
| Q91887667 | Prognostic indicators of new onset atrial fibrillation in patients with acute coronary syndrome |
| Q89492116 | Risk of Stroke in Patients With Atrial Fibrillation Is Associated With Stroke in Siblings: A Nationwide Study |
| Q47918027 | ST segment depression on 24-hour electrocardiography predicts incident atrial fibrillation in two population-based cohorts |
| Q31131029 | Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study |
| Q58744351 | Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation |
| Q46223779 | Structured care of patients with atrial fibrillation improves guideline adherence. |
| Q30395217 | Symptom burden, Metabolic profile, Ultrasound findings, Rhythm, neurohormonal activation, haemodynamics and health-related quality of life in patients with atrial Fibrillation (SMURF): a protocol for an observational study with a randomised [...] |
| Q64061038 | The association between alcohol consumption, cardiac biomarkers, left atrial size and re-ablation in patients with atrial fibrillation referred for catheter ablation |
| Q33848923 | The clinical impact of different coagulometers on patient outcomes |
| Q39018746 | The gap between indicated and prescribed stroke prevention therapies in a high-risk geriatric population |
| Q42377391 | Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed |
| Q37012454 | Validation of self-reported and hospital-diagnosed atrial fibrillation: the HUNT study |
| Q51836770 | Warfarin persistence among atrial fibrillation patients - why is treatment ended? |
Search more.